Blood Cancer United

Smart investments in research for leukemia, lymphoma, myeloma, and other blood cancers lead to scientific discoveries that improve and save the lives of patients everywhere.

Smart investments in blood cancer research fuel scientific discoveries that save lives, advancing treatments for leukemia, lymphoma, myeloma, and more.

Matthew Lunning leads lymphoma, cellular therapy, and research programs at the University of Nebraska Medical Center.

Financial assistance programs from Blood Cancer United are making costly blood cancer care more accessible to patients.

Francine M. Foss, MD Professor of Medicine Director, T-Cell Lymphoma Program Yale Cancer Center Yale School of Medicine New Haven, CT

Zanetta S. Lamar, MD Assistant Professor, Hematology & Oncology Maya Angelou Center for Health Equity Redox Biology and Medicine Center Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, NC

The Leukemia & Lymphoma Society monitors COVID-19 developments to protect employees, volunteers, donors, partners, and immunocompromised blood cancer patients.

Please visit the main LLS News page for all blood cancer updates including patient care, advocacy and fundraising.

Position Title: Light The Night Walk Community Intern – The Leukemia & Lymphoma Society, Greater Illinois Chapter

Position Title: Light The Night Walk Corporate Intern – The Leukemia & Lymphoma Society, Greater Illinois Chapter

Monthly giving allows recurring donations to Blood Cancer United.

Blood Cancer United accepts payroll deductions for mission support.

Financial worksheets help blood cancer patients address post-diagnosis concerns.

Executive Vice President, Chief Campaign & Field Development Officer

Ken Schwartz advises on mergers, acquisitions, and divestitures for private equity and corporate clients at Ernst & Young LLP.

Please send all media-related inquiries and interview requests to [email protected]. An LLS representative will respond as soon as possible.

Formerly The Leukemia & Lymphoma Society. More than 75 years of progress for people affected by blood cancer.

Our commitment to justice, dignity, and belonging takes two forms: a culture of Diversity, Equity, and Inclusion; (DEI) and a focus on advancing health equity for all.

LLS engages the court system and government oversight authorities to secure and maintain critical protections for patients with conditions like blood cancer by elevating patients’ voices in the legal record. Our legal efforts have been covered by journalists and cited by both lawmakers and judges in their opinions.

Blood Cancer United accepts donations to fund research, patient support, and advocacy.

Chemotherapy is the use of potent drugs or chemicals, often in combinations or intervals, to kill or damage cancer cells in the body.

The leading venture philanthropy initiative is searching for new portfolio partners.

So people with blood cancer can be about everything else.